The internationalization level of Chinese medical institutions continues to rise. More and more large top-tier hospitals are setting up international medical departments, equipped with multilingual service teams and designed to international standards. Many hospitals have already obtained JCI international accreditation, with service processes and quality management systems aligned with global benchmarks.
In terms of technological innovation, China has reached international advanced levels in cutting-edge fields such as CAR-T cell therapy, proton and heavy ion therapy, and robot-assisted surgery. The number of CAR-T clinical trials in China ranks first globally, and the number of commercialized products is on par with the United States. More and more international medical conferences are choosing to be held in China, and the influence of Chinese experts on the international academic stage continues to grow.
At the same time, international medical brands are accelerating their entry into the Chinese market. The pilot scope for wholly foreign-owned hospitals is expanding, and the number of Sino-foreign joint venture medical institutions continues to grow, bringing more international elements to China's medical market and offering more options for international patients.
